BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6326493)

  • 1. Evidence of a new type of phosphoribosylpyrophosphate synthetase with abnormal kinetic properties in hyperuricemias.
    Mousson B; Baltassat P
    Adv Exp Med Biol; 1984; 165 Pt B():1-4. PubMed ID: 6326493
    [No Abstract]   [Full Text] [Related]  

  • 2. Abnormal purine and pyrimidine metabolism in inherited superactivity of PRPP synthetase.
    Bory C; Chantin C; Boulieu R
    Adv Exp Med Biol; 1994; 370():15-8. PubMed ID: 7660879
    [No Abstract]   [Full Text] [Related]  

  • 3. Phosphoribosylpyrophosphate and enzymes of purine metabolism in erythrocytes from young hyperuricemic males.
    van Maris AG; Tax WJ; Oei TL; de Bruyn CH; Klein F; Geerts SJ; Veerkamp JH; Valkenburg HA
    Biochem Med; 1980 Jun; 23(3):263-71. PubMed ID: 6158313
    [No Abstract]   [Full Text] [Related]  

  • 4. Inherited phosphoribosylpyrophosphate synthetase superactivity due to aberrant inhibitor and activator responsiveness.
    Becker MA; Losman MJ; Simmonds HA
    Adv Exp Med Biol; 1986; 195 Pt A():59-66. PubMed ID: 3014841
    [No Abstract]   [Full Text] [Related]  

  • 5. Superactive phosphoribosylpyrophosphate synthetase with altered regulatory and catalytic properties.
    Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
    Adv Exp Med Biol; 1980; 122A():387-92. PubMed ID: 6158850
    [No Abstract]   [Full Text] [Related]  

  • 6. Human phosphoribosylpyrophosphate (PRPP) synthetase requirements for subunit aggregation.
    Losman MJ; Becker MA
    Adv Exp Med Biol; 1984; 165 Pt A():427-32. PubMed ID: 6326486
    [No Abstract]   [Full Text] [Related]  

  • 7. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.
    Becker MA
    J Clin Invest; 1976 Feb; 57(2):308-18. PubMed ID: 176178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAD synthesis by erythrocytes in phosphoribosylpyrophosphate synthetase (PRPPs) superactivity.
    Micheli V; Simmonds HA
    Adv Exp Med Biol; 1989; 253A():1-7. PubMed ID: 2560329
    [No Abstract]   [Full Text] [Related]  

  • 9. Pyrimidine nucleotides impair phosphoribosylpyrophosphate (PRPP) synthetase subunit aggregation by sequestering magnesium. A mechanism for the decreased PRPP synthetase activity in hereditary erythrocyte pyrimidine 5'-nucleotidase deficiency.
    Lachant NA; Zerez CR; Tanaka KR
    Biochim Biophys Acta; 1989 Jan; 994(1):81-8. PubMed ID: 2535789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRPP synthetase superactivity in lymphoblast lines.
    Becker MA; Losman MJ; Rimon D; Kim M
    Adv Exp Med Biol; 1986; 195 Pt A():51-8. PubMed ID: 3014839
    [No Abstract]   [Full Text] [Related]  

  • 11. Human erythrocyte phosphoribosylpyrophosphate synthetase. Dependence of activity on state of subunit association.
    Meyer LJ; Becker MA
    J Biol Chem; 1977 Jun; 252(11):3919-25. PubMed ID: 193850
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphoribosyl pyrophosphate synthetase and glutathione reductase in erythrocytes from hyperuricaemic and gout patients.
    Hardwell TR; Braven J; Shaw S; Whittaker M
    Clin Chim Acta; 1982 Dec; 126(3):217-26. PubMed ID: 6295664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the role of 5-phosphoribosyl-alpha-1-pyrophosphate synthetase in congenital hyperuricemia and gout: a simple isotopic assay and an activity stain for the enzyme.
    Johnson MG; Rosenweig S; Switzer RL; Becker MA; Seegmiller JE
    Biochem Med; 1974 Jul; 10(3):266-75. PubMed ID: 4366297
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnostic evaluation of phosphoribosylpyrophosphate synthetase activities in hemolysates.
    Losman MJ; Hecker S; Woo S; Becker MA
    J Lab Clin Med; 1984 Jun; 103(6):932-43. PubMed ID: 6327865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A spectrophotometric assay of phosphoribosyl pyrophosphate synthetase.
    Braven J; Hardwell TR; Seddon R; Whittaker M
    Ann Clin Biochem; 1984 Sep; 21 ( Pt 5)():366-71. PubMed ID: 6095727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human phosphoribosylpyrophosphate synthetase: relation of activity and quaternary structure.
    Becker MA; Meyer LJ; Huisman WH; Lazar CS; Adams WB
    Adv Exp Med Biol; 1977; 76A():71-9. PubMed ID: 193379
    [No Abstract]   [Full Text] [Related]  

  • 17. An inborn error of purine metabolism, deafness and neurodevelopmental abnormality.
    Simmonds HA; Webster DR; Lingam S; Wilson J
    Neuropediatrics; 1985 May; 16(2):106-8. PubMed ID: 2989725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic aspects of purine metabolism in cultured fibroblasts. A comparative study of cells from patients overproducing purines due to HGPRT deficiency and PRPP synthetase superactivity.
    Zoref E; de Vries A; Sperling O
    Monogr Hum Genet; 1978; 10():96-9. PubMed ID: 214700
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibitory effects of 2,3-DPG on enzymes of purine nucleotide metabolism.
    Yip LC; Balis ME
    Biochem Biophys Res Commun; 1975 Apr; 63(3):722-9. PubMed ID: 165811
    [No Abstract]   [Full Text] [Related]  

  • 20. Human phosphoribosylpyrophosphate synthetase. Comparison of purified normal and mutant enzymes.
    Becker MA; Kostel PJ; Meyer LJ
    J Biol Chem; 1975 Sep; 250(17):6822-30. PubMed ID: 169259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.